Recursion Pharmaceuticals, Inc. (RXRX)
3.46
-0.08
(-2.26%)
USD |
NASDAQ |
Mar 06, 16:00
3.455
0.00 (0.00%)
Pre-Market: 20:00
Recursion Pharmaceuticals Cash from Investing (Quarterly) : -1.244M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 27.53M |
| Tango Therapeutics, Inc. | -135.72M |
| Hims & Hers Health, Inc. | -83.68M |
| Novavax, Inc. | 20.48M |
| Geron Corp. | 21.14M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -46.07M |
| Cash from Financing (Quarterly) | 132.01M |
| Free Cash Flow | -380.44M |
| Free Cash Flow Per Share (Quarterly) | -0.0898 |
| Free Cash Flow to Equity (Quarterly) | -42.91M |
| Free Cash Flow to Firm (Quarterly) | -47.32M |
| Free Cash Flow Yield | -24.52% |